4baseCare Philippines

🇵🇭𝐌𝐚𝐠𝐤𝐚𝐢𝐬𝐚 𝐚𝐭 𝐮𝐧𝐭𝐢 𝐮𝐧𝐭𝐢 𝐧𝐚𝐭𝐢𝐧𝐠 𝐩𝐮𝐤𝐬𝐚𝐢𝐧 𝐚𝐧𝐠 𝐜𝐚𝐧𝐜𝐞𝐫!  🇮🇳𝐔𝐧𝐢𝐭𝐞𝐝 𝐚𝐬 𝐨𝐧𝐞, 𝐬𝐥𝐨𝐰𝐥𝐲 𝐰𝐞 𝐝𝐞𝐟𝐞𝐚𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 ! India and the Philippines—two nations rich in culture, tradition, and resilience—are now uniting for a shared mission: advancing precision oncology and transforming cancer care for diverse populations. In a landmark collaboration, 4baseCare and Linking Network for Cancer Services, Inc. Philippines have signed an #MoU, marking a pivotal step in leveraging genomic intelligence and clinical expertise to bring personalized cancer care to more patients. This partnership blends cutting-edge genomics with a patient-first approach, ensuring that every individual receives the care best suited to them. Why This Matters? Cancer is not one-size-fits-all—it’s shaped by genetics, environment, and lifestyle. This partnership fosters collaboration among #oncologists, #researchers, and healthcare providers across both nations, paving the way for precision-driven, #affordable, and #accessible cancer care. Just like the #Bayanihan spirit of the #Philippines and the unity in diversity of #India, this partnership stands as a testament to the power of collaboration in healthcare innovation. 🇮🇳🤝🇵🇭 Here’s to a future where precision oncology knows no borders! #4baseCare #LINCS #Philippines #PrecisionOncology #CancerCare #Genomics #IndiaPhilippinesCollaboration #Healthcare #Innovation Catherine Teh Necy Juat Hitesh Goswami Kshitij Rishi Sudharshan Elangovan, PhD Radha Madhavan Ananthakumar Jojo Flores

𝐔𝐧𝐥𝐨𝐜𝐤𝐢𝐧𝐠 𝐂𝐚𝐧𝐜𝐞𝐫’𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐱𝐢𝐭𝐲 𝐰𝐢𝐭𝐡 𝐆𝐞𝐧𝐨𝐦𝐢𝐜 𝐏𝐫𝐨𝐟𝐢𝐥𝐢𝐧𝐠 Cancer is not a one-size-fits-all disease—every case is unique, and so should be its treatment. At 4baseCare, we are transforming cancer care with Comprehensive Genomic Profiling (#CGP) to enable truly personalized treatment strategies. Our suite of precision oncology solutions provides #clinicians with critical molecular insights, guiding targeted interventions and improving patient outcomes. 𝐎𝐮𝐫 𝐆𝐞𝐧𝐨𝐦𝐢𝐜 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬: 𝐅𝐅𝐏𝐄 𝐓𝐢𝐬𝐬𝐮𝐞 𝐓𝐞𝐬𝐭 – 𝐒𝐨𝐥𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐲 𝐜𝐭𝐃𝐍𝐀 𝐓𝐞𝐬𝐭 – 𝐋𝐢𝐪𝐮𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐲 𝐒𝐨𝐋𝐢𝐐 𝐓𝐞𝐬𝐭 – 𝐈𝐧𝐭𝐞𝐠𝐫𝐚𝐭𝐢𝐯𝐞 𝐒𝐨𝐥𝐢𝐝 + 𝐋𝐢𝐪𝐮𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐲 With these innovative approaches, we are bridging the gap between advanced genomics and precision oncology, ensuring that every patient receives treatment tailored to their cancer’s genetic profile. 𝐓𝐨𝐠𝐞𝐭𝐡𝐞𝐫, 𝐰𝐞 𝐛𝐞𝐚𝐭 𝐜𝐚𝐧𝐜𝐞𝐫. #PrecisionOncology #GenomicProfiling #CancerResearch #LiquidBiopsy #SolidBiopsy #4baseCare #PersonalizedMedicine

𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐂𝐚𝐧𝐜𝐞𝐫 𝐂𝐚𝐫𝐞, 𝐎𝐧𝐞 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐚𝐭 𝐚 𝐓𝐢𝐦𝐞  Precision oncology is more than treatment—it's a #revolution. Instead of a one-size-fits-all approach, we’re pioneering a future where cancer care is as unique as the individuals it affects. By leveraging Comprehensive Genomic Profiling (#CGP), we unlock critical insights into the genetic blueprint of each patient's cancer, guiding smarter, targeted, and highly personalized therapies. 🚀 This breakthrough approach is redefining possibilities in oncology, leading to: ✅ Personalized Molecular Insights – Understanding the genetic drivers of cancer at an individual level. ✅ Data-Driven Decisions – Leveraging cutting-edge research for precision-based treatment strategies. ✅ Access to Targeted Therapy – Matching patients with treatments that specifically target their cancer’s unique characteristics. ✅ Improved Treatment Outcomes – Enhancing effectiveness, reducing unnecessary treatments, and improving quality of life. 💡 Together, we’re not just treating cancer—we’re transforming lives. #PrecisionOncology #CancerCare #Genomics #TargetedTherapy #4baseCare #LINCs Linking Network for Cancer Services, Inc. #PrecisionMedicine

An Ode to the Five Visionary Founders of Linking Network for Cancer Services, Inc. National Women’s Month, #Philippines Amidst the storm, when shadows grew, Five warriors rose, their vision true. In halls where healing hands reside, They forged a path, a beacon, a guide. To Dr. Catherine Teh, with scalpel keen, A force where few have ever been. A healer’s hand, a leader’s might, Breaking barriers, claiming light. To Dr. Necy Juat, steadfast and wise, A guardian where hope and duty lies. From policy halls to patient’s side, Her heart and knowledge, undenied. To Dr. christina galvez mentor bright, Where wisdom blooms in guiding light. A scholar’s grace, a surgeon’s skill, With every lesson, hearts she stills. To Dr. Jhade Lotus Peneyra teacher, guide, A flame in knowledge, far and wide. Her voice ignites, her mind inspires, To heal, to teach—her soul aspires. To Dr. Annielyn Beryl Ong-Cornel In service strong, in care excelled. Through private halls and state’s embrace, She walks with kindness, strength, and grace. Together they stand, unwavering, bold, A sisterhood of healers, their story told. For those in pain, for lives to mend, A mission steadfast—without end. A legacy, a light, a vow, To heal, to fight, to stand, to bow. For those in need, their voices ring, A symphony of hope, forever sing. #WomensDay #WomenInScience #Philippines #Inspiration #Steminist

Over the past decade, Next-Generation Sequencing (#NGS) has revolutionized cancer diagnosis and treatment globally by enabling rapid and comprehensive analysis of #DNA and #RNA. This advancement offers deeper insights into tumor biology, treatment resistance, and facilitates personalized therapy strategies. 𝐔𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝𝐢𝐧𝐠 𝐆𝐞𝐧𝐨𝐦𝐢𝐜 𝐓𝐞𝐬𝐭𝐢𝐧𝐠: 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐯𝐬. 𝐓𝐚𝐫𝐠𝐞𝐭𝐞𝐝 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐆𝐞𝐧𝐨𝐦𝐢𝐜 𝐏𝐫𝐨𝐟𝐢𝐥𝐢𝐧𝐠 (𝐂𝐆𝐏): Simultaneously analyzes hundreds of cancer-related genes, detecting various genetic alterations such as single nucleotide variants (SNVs), insertions/deletions, copy number variations (CNVs), gene fusions, and microsatellite instability (MSI). CGP is particularly beneficial for hard-to-treat cancers, double primaries, and recurrent diseases. 𝐓𝐚𝐫𝐠𝐞𝐭𝐞𝐝 𝐆𝐞𝐧𝐞𝐭𝐢𝐜 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬: Focuses on specific genes known to drive particular cancers, such as EGFR in lung cancer or BRCA1/2 in breast and ovarian cancers. While useful for quick decision-making when a specific mutation is suspected, this approach is limited in scope. Catherine Teh 🔗 Read more :- https://lnkd.in/g_DNQZbQ #Genomics #PrecisionMedicine #PrecisionOncology #CancerGenomics #NGS (Next-Generation Sequencing) #LiquidBiopsy #MolecularDiagnostics #CancerResearch #CancerAwareness #HealthcareInnovation #CancerCare

💜 COLLABORATION IS OUR STRONGEST CURE – PNCS 2025! 💜 "Collaboration is our strongest cure—unite expertise, bridge gaps, and empower every patient with timely, comprehensive cancer care. Philippine National Cancer Summit (PNCS) 2025: Unity in action! Cancer care is not just a medical challenge—it’s a shared responsibility. By working together, we can strengthen our healthcare system, improve access to treatment, and ensure every patient receives the care they deserve. #PNCS2025 #StrongerTogether #CancerCareForAll #UnityInAction #PCSCancerCommission #CancerAwareness #BridgingGapsincancerCare #LoveIsPurple #BeStrongerPH

In 2023, we took a bold step forward, we recognized that transforming healthcare requires strong partnerships. Fast forward 2025, we celebrate the power of collaboration—bringing together expertise, technology, and vision to make precision oncology more accessible in the Philippines 🇵🇭 and the rest of southeast Asia. This marks the beginning of a transformative era in genomic medicine for the Philippines as we solidify our partnerships with 4baseCare 🇮🇳 and Singapore Diagnostics (#SGD)—our key allies in making next-generation sequencing a local reality. Together, our partnership represent more than just agreements—they symbolize our shared vision of making #NGS accessible, affordable, efficient, and transformative. Here’s to a future where innovation meets global excellence—where precision medicine is not just a concept but a reality for every patient who needs it. Linking Network for Cancer Services, Inc. 4baseCare Philippines Necy Juat Hitesh Goswami

𝐃𝐞𝐜𝐨𝐝𝐢𝐧𝐠 #𝐄𝐆𝐅𝐑 𝐌𝐮𝐭𝐚𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 #𝐍𝐒𝐂𝐋𝐂: 𝐖𝐡𝐲 (#𝐒𝐨𝐋𝐢𝐐) 𝐜𝐨𝐦𝐛𝐢𝐧𝐞𝐝 𝐋𝐢𝐪𝐮𝐢𝐝 & 𝐓𝐢𝐬𝐬𝐮𝐞 𝐍𝐆𝐒 𝐌𝐚𝐭𝐭𝐞𝐫! 📌 #EGFR mutations are key drivers in lung adenocarcinoma (LUAD), especially in #Asian, #nonsmoking, and female patients.  🧬 Uncommon #EGFR mutations (8.9% of cases) are more frequent in smokers, linked to #KRAS & #TP53 mutations, high #TMB, and lower TKI efficacy. 𝐖𝐡𝐲 (#𝐒𝐨𝐋𝐢𝐐) 𝐜𝐨𝐦𝐛𝐢𝐧𝐞𝐝 𝐋𝐢𝐪𝐮𝐢𝐝 & 𝐓𝐢𝐬𝐬𝐮𝐞 𝐍𝐆𝐒 𝐌𝐚𝐭𝐭𝐞𝐫! 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐌𝐮𝐭𝐚𝐭𝐢𝐨𝐧 𝐃𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧 🔹 𝐓𝐢𝐬𝐬𝐮𝐞 𝐍𝐆𝐒: Identifies common, uncommon, and compound EGFR mutations + co-mutations impacting therapy.  🔹 𝐋𝐢𝐪𝐮𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐲 𝐍𝐆𝐒 (𝐜𝐭𝐃𝐍𝐀): Non-invasive, detects tumor heterogeneity & real-time changes. 𝐈𝐝𝐞𝐧𝐭𝐢𝐟𝐲𝐢𝐧𝐠 𝐂𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐌𝐮𝐭𝐚𝐭𝐢𝐨𝐧𝐬 🔹 𝐏𝐂𝐑 (𝐀𝐑𝐌𝐒, 𝐝𝐝𝐏𝐂𝐑) may miss compound mutations.  🔹 𝐍𝐆𝐒 detects all variants, guiding precise TKI selection. 𝐓𝐫𝐚𝐜𝐤𝐢𝐧𝐠 𝐑𝐞𝐬𝐢𝐬𝐭𝐚𝐧𝐜𝐞 & 𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐢𝐧𝐠 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 🔹 𝐊𝐑𝐀𝐒 (𝐆12𝐂) & TP53 mutations reduce TKI efficacy.  🔹 𝐍𝐆𝐒 helps identify MET & KRAS inhibitors, or immunotherapy options. 𝐃𝐲𝐧𝐚𝐦𝐢𝐜 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 & 𝐌𝐑𝐃 𝐃𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧 🔹 𝐓𝐢𝐬𝐬𝐮𝐞 𝐍𝐆𝐒: Establishes baseline mutation profile.  🔹 𝐋𝐢𝐪𝐮𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐲 𝐍𝐆𝐒: Tracks resistance mutations (T790M, C797S) & disease progression. ✨𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲: A combined Liquid + Tissue (SoLiQ) NGS approach ensures better mutation detection, personalized treatment, and improved patient outcomes! 𝐀𝐑𝐓𝐈𝐂𝐋𝐄 𝐋𝐈𝐍𝐊- https://lnkd.in/gqfsPFpW #TARGTIndiegene #PrecisionOncology #Genomics #CancerResearch #NGS #OncogenicDrivers #Immunotherapy #CancerCare

𝐓𝐨𝐠𝐞𝐭𝐡𝐞𝐫 𝐖𝐞 𝐁𝐞𝐚𝐭 𝐂𝐚𝐧𝐜𝐞𝐫! 4baseCare, An Illumina Accelerator Company, backed by Infosys Innovation Fund, is engaged in the development of cutting-edge precision oncology solutions, using advanced #genomics and next-gen digital health technology, to personalize patient care in oncology. We have developed a unique set of comprehensive genomic panels which allows #oncologists to choose the optimal targeted therapy for their Cancer patients. We also provide A Comprehensive Solution to support you through your Cancer Care Journey. Contact us- 📞 +916366843415 ( Bengaluru, India ) 📨 [email protected] 📞 +65 9759 5630- Radha Madhavan ( Manila, Philippines ) +63 9176521014- Chari D. Garcia ( Manila, Philippines ) 📨 [email protected] #PrecisionOncology #CancerResearch #CancerCare #NGS #CGP #Philippines #CGP

𝐍𝐨𝐭𝐞 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐅𝐨𝐮𝐧𝐝𝐞𝐫𝐬 ! -Hitesh Goswami Kshitij Rishi "As the founders of 4baseCare, we are forever driven by a mission to revolutionize precision oncology, and we are constantly working towards impactful #collaborations that advance Cancer Care. With a strong commitment to drive #innovation, #affordability and #accessibility in the field of Precision Oncology, we are gearing up for more exciting new #partnerships that will further this vision. Stay tuned as we continue to push boundaries and bring cutting-edge solutions to hashtag #patients, #clinicians and healthcare providers worldwide!" #OncologyLeaders #CancerResearch #PrecisionOncology #Startups #Healthcare #Innovation #CancerCare #Global #BusinessLeaders #CancerCare